BDCI Q1 2026 Earnings Positive EPS of 005 Reported Despite Absence of Revenue Details Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline WD Q1 2026 Earnings EPS Surges Past Estimates with 62 Surprise SU Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Amid Market Challenges DCH Q1 2026 Earnings Massive EPS Surprise Drives Stock Up 39 WGRX Q1 2026 Earnings Negative EPS and No Revenue Reported Stock Plunges 22